Independent Equity Research — Initiation Report date: 2026-06-29 · Price (2026-06-26): $139.71 Sector: Industrials · Building Products & Security · CIK: 0001579241 · FY-end: December
⚡ Claude’s Take
This is the author’s own independent, subjective opinion and general information only. It is not investment advice and not a recommendation to buy or sell any security. Everything below this block (the analysis proper) is deliberately position-free and carries no recommendation or price target.
Verdict: HOLD / accumulate-on-weakness / NOT-a-short. Medium conviction. Fair-value zone ~$150–175 (≈16–18.5x FY26–27 adjusted EPS of ~$8.80 / ~$9.4). Start accumulating into the low-$120s–$130; do not chase above ~$180 (the prior all-time high). Tag: “The lock is Schlage; the discount is the construction cycle’s.”
Allegion is a genuinely high-quality business — a ~19% ROIC, 45%-gross-margin, spec-driven door-hardware franchise whose Schlage / Von Duprin / LCN brands are written into building codes and architect specifications across US non-residential construction. It out-earns its larger global rivals (ASSA ABLOY, dormakaba) on every margin and return line despite being the smallest of the three, the empirical fingerprint of a real local competitive advantage. And it is cheap on its own history: at $139.71 the stock trades ~16x forward earnings and ~5.7% free-cash-flow yield, the lower half of its eight-year multiple range and the 16.7th percentile of its own valuation history — even though EPS compounded +39% over 2021→2025 while the stock went nowhere. The market is underwriting only ~2–2.5% perpetual growth into a franchise earning two-to-three times its cost of capital. That is the classic de-rated-quality setup.
What keeps this a HOLD rather than a table-pounding buy is that the de-rating is not only sentiment. The factor tape correctly identifies ALLE as a low-beta, rate-sensitive, late-cycle building-products cyclical with a heavy home-construction loading and a five-year dead-money track record — and the non-residential construction cycle is genuinely late. The Q1-2026 print (the first adjusted-EPS decline in years, a self-inflicted International ERP stumble, ~110–220 bps of segment margin compression, and a tariff overhang) is management’s claimed “transitory blip,” but it is also exactly what the early innings of a cyclical rollover look like. The whole call reduces to one variable: does US non-residential volume hold, or roll into 2027? If it holds, this is a quality compounder mispriced as a commodity cyclical at a decade-cheap multiple. If it rolls, the factor tape is right and the stock can stay cheap for another year or two — the “value trap” risk the dead-money base rate warns about. The skew is favorable but not screaming (roughly −18% to a ~$115 bear, +30% to a ~$185 bull). Conviction flips bullish on two quarters of positive Americas organic volume (not just price) plus an International recovery and margin re-expansion; flips bearish on two quarters of negative Americas organic volume with the architecture billings index stuck below ~48. The single best piece of supporting evidence for the long side: a multi-year pattern of genuine open-market buying by CEO John Stone (~$5M, 2022–24) and several directors — uncommon conviction for a company of this quality. The best evidence for caution: that volume, not price, has done almost none of the recent growth.
📈 Stock Price Action — Five-Year Event Map
Over the trailing ~60 months Allegion round-tripped a full cycle: a COVID trough near $79 (March 2020) → a long grind to an all-time high of ~$179.77 (February 6, 2026) → a sharp ~−22% slide to $139.71 (June 26, 2026). The 52-week range is roughly $125.65 (May 15, 2026) to $179.77; the stock sits ~22% below its all-time high and ~+11% off its May-2026 low, back above its 21-day moving average (~$132) but still below its 200-day (~$146). The drawdown was driven not by an earnings collapse — earnings kept rising — but by multiple compression layered onto a genuine but management-claims-transitory Q1-2026 operating stumble. Price moves below are Fact; the attributed drivers are Interpretation.
| # | Period | Approx. move | Price (~from → to) | Primary driver(s) | Fact / Interp |
|---|---|---|---|---|---|
| 1 | Feb–Mar 2020 | −40% | ~$131 → ~$79 | COVID crash; non-residential construction-shutdown fear | Fact / Interp |
| 2 | Apr 2020–Sep 2021 | +88% | ~$79 → ~$148 | Recovery + post-COVID quality/compounder bid; multiple peaks at ~21x EV/EBITDA, ~24x P/E | Fact / Interp |
| 3 | Sep 2021–Oct 2022 | −38% | ~$148 → ~$83–87 | 2022 rate-shock / recession-fear de-rating of cyclicals (earnings still rose — pure compression) | Fact / Interp |
| 4 | Oct 2022–Feb 2026 | +106% | ~$87 → ~$179.77 (ATH) | Multi-year grind to ATH: EPS compounding ($5.19→$7.43), Stanley Access + bolt-ons, GM 40%→45%, resilient spec demand | Fact / Interp |
| 5 | Feb–Apr 2026 | −17% | ~$179.77 → ~$148 | Pre-earnings de-risking; non-res late-cycle worry + tariff overhang building | Fact / Interp |
| 6 | Apr 28, 2026 | −7.1% (1d) | ~$148.40 → ~$137.86 | Q1-26 print: first adj-EPS decline (−3.2%), Intl organic −5.3% on self-inflicted ERP, Americas margin −110 bps | Fact / Interp |
| 7 | Apr–May 2026 | −9% | ~$138 → ~$125.65 | Continued estimate cuts (MS→$142, JPM→$150); tariff/margin + non-res-rollover fears | Fact / Interp |
| 8 | May–Jun 2026 | +11% | ~$125.65 → $139.71 | Partial bounce; management frames ERP/International as transitory, $500M buyback authorized, spec “strong” | Fact / Interp |
Cycle narrative. Events 1–3 are macro: a COVID crash, a V-shaped quality bid that drove the multiple to its all-time peak, and the 2022 rate-shock de-rating (note earnings rose through it — the first instance of the recurring pattern that the stock’s swings are multiple events on a rising earnings base). Event 4 is the four-year fundamental grind that took EPS and the stock to new highs on the back of the Stanley Access acquisition, steady margin recovery, and resilient specification-driven non-residential demand. Events 5–8 are the current de-rating: a pre-earnings risk-off, the −7.1% single-day reaction to a genuinely weak Q1-2026 (the proximate catalyst), further estimate cuts, and a partial bounce as management argued the stumble is temporary. The franchise is at a ~22% drawdown from its February-2026 peak that is, in substance, a sentiment/multiple de-rate plus one bad operating quarter — not a balance-sheet or secular impairment.
1. Executive Summary
Allegion plc is a pure-play maker of security hardware around the door — mechanical and electronic locks, exit (panic) devices, door closers, automatic entrances, and the access-control credentials and software that increasingly wrap them. Spun out of Ingersoll-Rand in November 2013 and domiciled in Dublin, it nonetheless reports as a US filer (calendar-year 10-K). Its economic center of gravity is overwhelmingly North American: the Allegion Americas segment generated FY2025 revenue of $3,218.8M (79% of the total $4,067.3M) and segment operating income of $896.5M (92% of segment profit) at a 27.9% margin, while Allegion International — a sub-scale, mostly-Continental-European collection of mechanical brands now being bolted into an electronics platform — earned just a 9.0% margin on the remaining 21% of revenue.
The investment case is one of quality versus price. On the quality side, Allegion is, by the numbers, the best franchise in its industry: a 45.2% gross margin, 21.1% operating margin, and ~19% ROIC that exceed those of both larger global peers — ASSA ABLOY (15.5% operating margin, ~10% ROIC) and dormakaba (10.4% operating margin). A #3-by-revenue player out-earning the global #1 by five-to-six margin points is the empirical signature of a genuine local competitive advantage: Schlage, Von Duprin and LCN are spec’d into building plans by architects, mandated by fire/egress codes, replaced one-for-one off a decades-deep installed base, and distributed through the densest commercial channel in the US. On the price side, the stock is cheap on its own history — ~16x forward adjusted EPS, ~13x forward EV/EBITDA, a 5.7% FCF yield, the lower half of an eight-year multiple range, and the 16.7th percentile of its own valuation history — despite having compounded EPS +39% from 2021 to 2025. The five-year stock chart is flat (a ~1.8% annualized total return, Sharpe near zero) entirely because the multiple compressed from a ~21x EV/EBITDA peak to ~13–14x, fully absorbing the earnings growth.
The reason it is cheap, and the reason this is a HOLD rather than a slam-dunk, is the non-residential construction cycle. The factor tape prices ALLE as a low-beta, rate-sensitive, late-cycle building-products cyclical, and the Q1-2026 print gave that view ammunition: the first adjusted-EPS decline in years (−3.2%), an International organic revenue drop (−5.3%) on a self-inflicted ERP implementation failure, ~110–220 bps of segment margin compression, decelerating electronics, soft residential, and a ~1%-of-COGS tariff/inflation headwind to be offset by price. Management frames the International stumble as temporary and reports “strong” specification activity in Americas non-residential, affirming a full-year guide of +2–4% organic growth and $8.70–8.90 adjusted EPS. Capital allocation is balanced and disciplined — high mechanical-hardware cash flow redeployed into a $1.7B run of electronics/access-control M&A (Stanley Access Technologies 2022, a nine-deal 2025 spree anchored by ELATEC, DCI in 2026), an ~11%/year dividend at a conservative 27% payout, and an opportunistically throttled buyback ($500M freshly authorized in April 2026) — with ROIC holding ~19% and no goodwill impairments through the spree. The two governance watch-items: no ROIC metric anywhere in executive compensation, and goodwill-plus-intangibles now at 52% of assets. The reassuring offset is genuine multi-year open-market buying by the CEO and several directors.
The embedded-expectations math is the crux: at $139.71 the market prices ~2–2.5% perpetual growth into a 19%-ROIC franchise. If the Q1 stumble is transitory and non-residential volume holds, that is a mispricing of quality as commodity cyclicality. If non-residential rolls into 2027, the cheap multiple is a value trap that can persist. The body that follows takes no position; it lays out the evidence on both sides.
2. Business Overview
What Allegion sells. Allegion is a focused security-hardware company — not a diversified industrial, but a specialist in the products that secure, control, and provide safe egress through a door. The portfolio spans five product families across 40+ brands: (1) door controls and exit devices — closers and “panic hardware” for emergency egress (Von Duprin, LCN, CISA, Briton, Stanley Access Technologies); (2) doors, frames, glass and accessories (Steelcraft, Republic, Ives, Glynn-Johnson, Falcon, Trimco, TGP); (3) electronic security, access control, credentials and workforce-time systems (Schlage, SimonsVoss, CISA, ELATEC, Interflex, Bricard, Zentra); (4) mechanical locks, locksets and key systems (Schlage, CISA, Falcon, AXA, Gainsborough, Bricard); and (5) services and software — inspection/maintenance/repair of automatic entrances, plus nascent SaaS (Interflex, Yonomi/Zentra). [Fact: FY2025 10-K, Item 1.]
By the nature of revenue, FY2025 split Mechanical products $2,713.9M (66.7%), Electronic products $1,075.1M (26.4%), and Services & software $278.3M (6.8%). By destination, U.S. $3,049.8M (75.0%) and non-U.S. $1,017.5M (25.0%). [Fact: 10-K Note 20 disaggregation.] The core remains a two-thirds-mechanical, replacement-heavy hardware business; the electronic mix is meaningful and rising but the secular software story is still small.
Segments — Americas is the franchise. Allegion reports two segments, and the asymmetry is the single most important fact about the company:
| Segment ($M, FY2025) | Revenue | % of rev | Segment OI | % of OI | Op margin | Segment assets | Pre-tax seg. ROA |
|---|---|---|---|---|---|---|---|
| Allegion Americas | 3,218.8 | 79.1% | 896.5 | 92.1% | 27.9% | 2,732.5 | ~32.8% |
| Allegion International | 848.5 | 20.9% | 76.5 | 7.9% | 9.0% | 1,886.1 | ~4.1% |
| Total (segment) | 4,067.3 | 100% | 973.0 | 100% | — | — | — |
[Fact: 10-K Note 20 / MD&A. Total segment OI $973.0M reconciles to consolidated operating income $859.5M after unallocated corporate costs.] Americas earns roughly three times International’s operating margin and generates >90% of segment profit on ~79% of revenue. The consolidated 21.1% operating margin therefore understates the underlying franchise: the US non-residential commercial business is the real asset, and International dilutes it. Critically, International’s assets ballooned +$740M in FY2025 (from $1,146M to $1,886M) — almost entirely the ELATEC acquisition and the 2025 deal spree — yet its operating income rose only +$10.2M, dropping segment ROA to ~4%. Capital is flowing into the lower-return segment (a theme revisited in ).
Channels, customers, and the revenue mix. Allegion sells commercial/institutional product through specialty distribution, wholesalers and e-commerce, and residential product through DIY home-improvement centers (Home Depot, Lowe’s), online channels and specialty showrooms; Stanley Access Technologies, Interflex and portable security are sold more directly. The ten largest customers are ~26% of revenue, with no single customer ≥10% — healthy diversification. [Fact: 10-K Customers.] Revenue is a blend of (a) new-construction project revenue — cyclical, specification-driven, and lagging non-residential starts because hardware is specified late in a build; (b) renovation/retrofit/code-upgrade demand; and © aftermarket replacement and break-fix, plus Stanley service contracts and early-stage SaaS. The aftermarket replacement stream is the de-facto annuity — a failed Von Duprin is replaced with a Von Duprin; an installed Schlage master-key system is expanded in Schlage — but Allegion does not separately quantify recurring vs. project revenue, an important disclosure gap (Open Question ). The 6.8% services-and-software line is the only explicitly “recurring” disclosure, and it is still small.
Cost base and geography. Allegion runs 37 principal production/assembly facilities (22 Americas, 15 International); ~45% of employees are in the US, ~55% outside, on a base of ~13,300. A large share of the US residential portfolio is manufactured in Baja, Mexico under the IMMEX/Maquiladora program; COGS sourcing is ~20–25% Mexico, <5% China, and 5–10% other non-US. [Fact: 10-K Production / Human Capital.] The Mexican footprint is simultaneously a structural low-cost advantage in US residential and the principal tariff/USMCA exposure. Revenue is modestly seasonal, weighted to Q2/Q3 with the Northern-Hemisphere construction and DIY season.
Verdict. Allegion is a focused, well-diversified-by-customer security-hardware maker whose economics are concentrated in one outstanding business — US non-residential commercial door hardware — surrounded by a soft residential flank and a sub-scale, low-return International segment that is currently absorbing acquisition capital. The right way to value the company is to value the Americas franchise and haircut International, not to take the blended margin at face value.
3. Industry Dynamics
Structure: globally fragmented, locally oligopolistic. Allegion’s own 10-K describes its markets as “highly competitive and fragmented throughout the world, with a number of large multi-national companies and thousands of smaller regional and local companies,” a fragmentation that “primarily reflects local regulatory requirements and highly variable end-user needs.” [Fact: 10-K Industry & Competition.] That single sentence is the key to the industry. At the global level, door hardware and access control is fragmented — the top ~15 players hold only ~20% of a market thousands of regional firms also serve. But at the local level — and specifically in US non-residential commercial hardware — the structure is a tight oligopoly. Allegion (Schlage/Von Duprin/LCN) and ASSA ABLOY (Sargent, Corbin Russwin, Yale, Adams Rite, McKinney) split the bulk of the spec-driven commercial profit pool; dormakaba (Swiss) and Fortune Brands Innovations (Master Lock, Kwikset-era residential) are smaller in US commercial. The local concentration, not the global fragmentation, is what determines profitability — and it is precisely what protects the incumbents.
Market size and profit pools. Public industry estimates size the global door-hardware/locks market at roughly $25–30B and the faster-growing electronic access-control market at ~$10–13B compounding high-single/low-double digits (vs. low-single digits for mechanical). [Assumption: industry-consensus public estimates and an internal peer (ASSA ABLOY) analysis; treat as order-of-magnitude, not 10-K-sourced.] ASSA ABLOY (~$14–15B revenue) is the global #1, roughly 2–3x Allegion’s $4.1B; dormakaba is ~$3B. The profit pool, however, is distributed very differently from revenue: it concentrates disproportionately in US/North-American non-residential spec hardware (exit devices, closers, commercial locksets, electrified hardware for institutional buildings), which is exactly the slice Allegion indexes to. That is why the #3 player by revenue is the #1 by margin — Allegion’s 27.9% Americas margin against ASSA’s ~15–16% blended and dormakaba’s ~10% reflects positioning in the richest niche, not merely scale.
Cyclicality and end markets. Demand is tied to “the strength and stability of institutional, commercial and residential construction and remodeling markets,” which the 10-K names as a top forward-looking risk. [Fact: 10-K FLS / Risk Factors.] But the cyclicality is more cushioned than a blunt “construction cyclical” label implies, for three reasons. First, the non-residential mix skews toward institutional end-markets — education (schools/universities), healthcare (hospitals), and government — which are funded by public budgets and life-safety mandates rather than purely by the private capex cycle, and are less volatile than commercial office or retail. Second, a large share of demand is renovation, retrofit, and code-upgrade, which is far steadier than new construction. Third, the aftermarket replacement stream is non-discretionary and tied to the installed base, not to new starts. New construction is the cyclical, lagging piece — and it is where the late-cycle worry sits. Residential (a smaller share of Americas, single- and multi-family) is the most rate/housing-sensitive piece, and it was flat-to-down through Q1-2026.
Regulation as a structural driver and an entry barrier. Allegion’s products are “life-safety” items “generally installed on fire doors and facility entrances and exits”; exit devices “provide rapid egress … in an emergency,” and all of it “must meet local and national building and safety code requirements.” [Fact: 10-K Products / Sales & Marketing.] Fire-door, egress (panic-hardware), and ADA-accessibility codes mandate compliant hardware on commercial and institutional openings; the codes are enforced by inspection, are periodically tightened, and are replacement-forcing. This is a regulatory demand floor that is non-discretionary — a building cannot legally operate with a non-compliant exit device — and a certification barrier (UL/ANSI/BHMA Grade-1 testing per SKU) that screens out cheap entrants for whom a failed certification means life-safety liability. Allegion sits on the standards bodies that write these codes (BHMA, DHI, AAADM, AIA, NFPA-adjacent groups; ARGE in the EU; the Door Hardware Federation in the UK), a soft regulatory-capture advantage at the rule-making table.
Verdict: structurally good — for the incumbent positioned in US non-residential. The industry is locally consolidated/oligopolistic, protected by codes and certification and specifier lock-in, replacement-heavy, only moderately cyclical (cushioned by institutional and life-safety demand), and carried by a real secular electronics tailwind. The structural negatives are confined to two zones: (a) residential/DIY, which is commoditized, exposed to retailer power and smart-lock price competition; and (b) the global fragmentation that leaves international operations sub-scale and low-return. The profit pool Allegion owns — US non-residential spec hardware — is one of the better niches in all of building products.
4. Competitive Position (The Moat)
The financial fingerprint of a moat. The most efficient way to test a moat is to ask whether it shows up in the numbers, and Allegion’s do. Benchmarked against the only two named global peers:
| Metric (FY latest, ROIC.ai) | Allegion | ASSA ABLOY | dormakaba |
|---|---|---|---|
| Gross margin | 45.2% | 42.6% | 41.0% |
| Operating margin | 21.1% | 15.5% | 10.4% |
| ROIC | ~19% | ~10% | ~10%* |
| Net margin | 15.8% | 9.6% | 3.4% |
[Fact: ROIC.ai get_profitability_ratios, 2026-06-29. *dormakaba’s ROIC.ai print is distorted by a low net-income denominator; read its 10.4% operating margin.] Allegion earns the highest gross margin, the highest operating margin, and the highest ROIC of the three despite being the smallest by revenue. And its Americas segment alone, at 27.9%, runs at ~1.8x ASSA’s blended margin and ~2.7x dormakaba’s. A smaller player out-earning larger rivals by five-to-eleven margin points is not explained by scale — it is the signature of a genuine local competitive advantage. The blended consolidated number understates it because the no-moat International segment dilutes the franchise.
Naming the mechanism (Greenwald taxonomy). The moat is a combination dominated by customer captivity and intangible assets, reinforced by local economies of scale:
- Specification lock-in / switching costs (the core). Schlage, Von Duprin and LCN are written into building specifications by architects, security consultants, and Allegion’s own specification writers early in a building’s design. Once a hardware schedule is spec’d, it propagates through the general-contractor → distributor → installer chain; locksmiths and distributors are trained and stocked on the brand; keying systems, door templates and door prep are brand-specific. Switching mid-project means re-specifying, re-certifying, and re-training — friction no specifier will absorb for a low-ticket item that is a fraction of total project cost. Workflow tools like Overtur (door-hardware coordination inside Revit/BIM) deepen the lock-in into the architect’s software.
- Installed-base / aftermarket captivity (the annuity). A building’s master-key system, door prep and exit-device footprint create a one-for-one replacement loop. A failed Von Duprin 98/99 is replaced with a Von Duprin; rekeying or expanding a Schlage master-key system stays Schlage. Decades of installed base produce a high-margin recurring replacement stream the incumbent harvests at low cost. (Industry peers such as ASSA ABLOY report roughly two-thirds of revenue from aftermarket/replacement/service — a structural feature of the whole industry. Allegion does not disclose its own split, an open question.)
- Intangibles — brand + certification. These are century-old, category-defining brands: Von Duprin invented the exit device (1908), Schlage the cylindrical/push-button lock (1920s), LCN the door closer (1926). In a category where product failure equals life-safety liability, that brand trust is itself a barrier, and per-SKU UL/ANSI/BHMA Grade-1 certification is a slow, costly entry barrier. Specifiers default to trusted, certified, litigation-safe brands.
- Local economies of scale + distribution density. Allegion has the densest US commercial distribution and specifier network and a low-cost Baja manufacturing base. The scale advantage is local (US non-residential), which is exactly why Allegion out-margins the larger-but-globally-dispersed ASSA ABLOY — Greenwald’s point that local scale within a defensible market beats global size spread thin.
Greenwald tests. Both barrier-to-entry tests pass for US non-residential: market-share stability (Allegion’s brands have held commercial leadership for decades against a stable, consolidated competitive set with no disruptive share shifts) and persistent high ROIC (18–22% across 2019–2025, through a full cycle). Strip the spec lock-in, installed-base and brand, and the 27.9% Americas margin would converge toward ASSA’s ~15% — the moat directly underwrites the premium economics.
Pressure-test #1 — electronic / smart-lock disruption. The bear claim is that the shift to electronic access control commoditizes mechanical locks and invites technology entrants (Apple/Google wallet credentials, Amazon, August, the failed Latch, native phone-as-key). The threat is real but asymmetric by segment. In residential/DIY, it is genuine: smart locks are a features-and-price race dominated by retailer and Big-Tech platform power, and this is Allegion’s lower-margin, less-defended flank (residential was flat-to-down in Q1-2026). In non-residential/commercial — the profit pool — electronics is largely a tailwind Allegion captures, not a disruption, because an electrified exit device or lock still must integrate with the certified mechanical opening, the fire/egress code, and the door schedule, which is precisely where Allegion is spec’d. Allegion monetizes the shift through Schlage XE360 and wallet credentials, SimonsVoss, ELATEC (readers), Interflex (workforce/time SaaS) and Zentra (multifamily); the credential/software layer can add ecosystem switching costs rather than remove them. The risk that does bite is margin mix (electronics and bought-in International electronics carry lower gross margins than the ultra-high-margin mechanical core) and the long-run possibility that cloud access control disintermediates reader/credential hardware — but the certified mechanical opening on a commercial fire/egress door is not going away.
Pressure-test #2 — is the moat eroding? Evidence against erosion: Americas operating margin is still expanding (26.0% → 27.1% → 27.9% over FY2023–25); pricing power is intact (Q1-2026 non-residential growth was “driven by price”); ROIC is stable and high. Evidence for caution: the consolidated electronics CAGR is modest and lumpy; International is a low-return capital sink; growth is increasingly acquired (the nine-deal 2025 spree) rather than organic; and the secular shift moves value toward software/credentials where Allegion is a fast-follower, not the inventor. Net: the core moat (US non-residential mechanical and electrified spec hardware) is intact and arguably widening on price; the periphery (residential, International, pure software) is where erosion risk and capital misallocation concentrate.
Marathon capital-cycle read. US non-residential door hardware sits at the favorable end of the capital cycle — high, persistent returns that do not attract destructive new capacity, because codes, certification, spec lock-in and brand are real barriers (high returns + no supply response = the “good” quadrant). The one arena where new capital is flooding in — and where Marathon would warn on future returns — is electronic/smart access control (VC, Big Tech and ASSA all investing heavily), concentrated in the residential/credential layers. The second capital-cycle flag is on Allegion’s own balance sheet: the 2025 deal spree pushed International assets up ~65% for +$10M of operating income — deploying into the lower-return segment.
Verdict: a real, durable moat in the US non-residential core — geographically and product-concentrated. Customer captivity (spec + installed-base replacement) plus intangibles (century brands + certification) plus local scale/distribution, empirically proven by best-in-class margins and ROIC and by still-expanding Americas margins with intact pricing power. The moat is wide in US non-residential commercial/institutional hardware and narrow-to-absent in residential/DIY and in International. Smart-lock disruption is a residential-flank and mix risk, not a commercial-core kill-shot. Primary watch-items: electronics-driven mix dilution of the mechanical margin, the follower position in software/credentials, and capital allocation into the low-return International segment.
5. Growth History and Forward Opportunities
The historical record. Revenue grew from $2,854M (2019) to $4,067M (2025), a ~6.1% CAGR, but the path is more informative than the average:
| FY | Revenue ($M) | Growth | Diluted EPS | Gross margin | Op margin |
|---|---|---|---|---|---|
| 2019 | 2,854.0 | — | $4.26 | 43.9% | 20.0% |
| 2020 | 2,719.9 | −4.7% | $3.39 | 43.3% | 20.0% |
| 2021 | 2,867.4 | +5.4% | $5.34 | 42.0% | 18.5% |
| 2022 | 3,271.9 | +14.1% | $5.19 | 40.4% | 17.9% |
| 2023 | 3,650.8 | +11.6% | $6.12 | 43.3% | 19.6% |
| 2024 | 3,772.2 | +3.3% | $6.82 | 44.2% | 20.7% |
| 2025 | 4,067.3 | +7.8% | $7.43 | 45.2% | 21.1% |
[Fact: ROIC.ai / 10-K.] Three observations. First, the 2022–23 surge was substantially acquired — the Stanley Access Technologies deal added ~$430M of revenue (and initially diluted margin). Second, diluted EPS compounded +39% from $5.34 (2021) to $7.43 (2025) — driven by ~5.4% revenue CAGR, ~470 bps of gross-margin recovery (40.4% trough in 2022 to 45.2%), operating leverage, and a modest buyback. Third — and this is the entire valuation story — the stock did essentially nothing over that span because the multiple compressed in lockstep with the earnings growth.
Organic vs. acquired, and the quality of recent growth. The composition of FY2025 Americas growth is revealing: Pricing +3.6%, Volume +1.6%, Acquisitions +1.8%, FX −0.1% = +6.9%. [Fact: 10-K MD&A.] Most of the organic growth is price, not volume — evidence of genuine pricing power, but also of a mature, low-unit-growth core. In Q1-2026 the pattern intensified: enterprise organic +2.6% was “driven by price realization, partially offset by volume declines,” residential was flat, and electronics decelerated from double-digit to mid-single-digit growth on a tough comparison. Price-led growth is high-margin and a moat tell, but a franchise growing units at ~1–2% is, structurally, a low-organic-growth compounder that leans on price, mix, M&A and buyback to reach high-single-digit EPS growth.
Forward opportunities. (1) Electronics / access control is management’s headline growth driver — electronic products are ~26% of revenue and rising, with Americas electronics up low-double-digits in FY2025; adoption rates in commercial access control are still climbing, and Allegion is layering in credentials-in-wallet, SimonsVoss, and ELATEC readers. This is real but slow and partly bought; it is the most credible multi-year organic lever. (2) International self-help — recovering International margins from 9% toward the mid-teens (via the ELATEC electronics platform and post-ERP normalization) is a swing factor for consolidated margin, though the segment’s ~4% ROA makes this a “fix-it,” not a compounder. (3) Specification share gains and adjacency cross-sell — DCI (West Coast doors) lets Allegion sell complete door-and-hardware packages and win share by improving lead times and freight cost. (4) Aftermarket/services — converting the installed base into more service and software revenue (still only 6.8% of sales).
Verdict: high-quality but modest-velocity growth. The economics of the growth are excellent — pricing-led, high-margin, moat-consistent — but the organic volume engine is slow (~1–2% units), so reaching the high-single-digit EPS growth management targets requires price, mix, M&A and buyback all pulling together. This is a compounder, but a low-octane one whose forward rate depends on electronics adoption and continued accretive capital deployment rather than on unit demand. It is “high-quality growth” of the durable-but-unspectacular kind.
6. Financial Quality
Margins and their trajectory. Allegion’s margin structure is the proof of the franchise: gross margin recovered from a 40.4% inflation-shock trough in 2022 to 45.2% in 2025, operating margin from 17.9% to 21.1%, and EBITDA margin to 24.4% ($992.7M). [Fact: ROIC.ai / 10-K.] The recovery reflects price/cost discipline catching up to 2021–22 input inflation, productivity, and mix. The forward question (flagged in Q1-2026) is whether the ~470 bps of gross-margin recovery is sustainable as (a) tariffs add ~1% of COGS, (b) lower-margin acquisitions (DCI, International electronics) dilute mix, and © the cycle pressures volume leverage. Management’s Q1-2026 guide assumes price/cost nets to neutral on operating-income dollars — a claim to be tested over the next two quarters.
Returns on capital — read ROIC, not ROE. Reported ROE is 31.6%, but it is not the right metric: cumulative buybacks and goodwill have driven tangible common equity negative (a −27% TCE ratio), so ROE and P/B are mechanically distorted. The clean read is ROIC ~19% (ROIC.ai return_on_inv_capital; return_on_cap 18.1%), stable in an 18–22% band across 2019–2025. At a ~7.5% WACC, that is roughly 2.5x the cost of capital — and, crucially, it has held through ~$1.7B of M&A since 2022, which is the key evidence that the acquisitions have not (yet) destroyed value. The one caveat: goodwill ($1,912M) plus intangibles ($826M) are now 52% of total assets ($5,224M), so the ROIC denominator is heavy with acquired intangibles; the underlying mechanical-core ROIC (ex-goodwill) is far higher.
Cash generation. Allegion is a strong, clean cash generator. FY2025 operating cash flow was $783.8M; with capex of ~$90M, free cash flow was ~$690M (~$8/share, ~5.7% FCF yield at $139.71). [Fact: ROIC.ai cash-flow statement — note its “free cash flow” field of $783.8M is OCF not net of capex, a recurring data gotcha; the real figure subtracts capex.] FCF/net-income conversion has run >1.0x every year for seven years, and Allegion guides FY2026 “available cash flow” conversion to 85–95% of adjusted net income. There is no quality-of-earnings red flag here — net income converts to cash, working capital is well-managed (cash-conversion cycle ~76 days), and SBC is modest (~$30M/year, ~0.7% of revenue), so the gap between GAAP and adjusted EPS is driven mainly by acquisition-related intangible amortization, not by aggressive add-backs.
Balance sheet. Net debt is $1,624M, ~1.6x EBITDA (1.7x on the company’s adjusted measure), comfortably investment grade, with $356M of cash and ~$190M drawn on the revolver at year-end. [Fact: 10-K / ROIC.ai.] This is a conservatively levered balance sheet that leaves meaningful M&A and buyback firepower — and the leverage is structural, not a financing-engineering risk.
Verdict: high financial quality — economics that improve with scale, and clean cash. Margins are best-in-class and have been expanding; ROIC of ~19% is genuinely high and durable (and is the metric to use, given the buyback-distorted ROE/book); cash conversion is strong and honest; the balance sheet is investment-grade with optionality. The legitimate watch-items are mix-driven margin dilution from acquisitions/electronics and the 52%-of-assets goodwill load — not earnings quality, which is sound.
7. Capital Allocation
The strategy: redeploy mechanical cash into electronic access control. Allegion generates far more cash than its low-capex core can reinvest, and management’s central capital-allocation choice has been to redeploy it into the faster-growing electronics/access-control adjacency through M&A, in three eras:
- Stanley Access Technologies (2022). Closed July 5, 2022 for $923.1M, financed with 5.411% senior notes and the revolver. The purchase-price allocation was 92.5% goodwill + intangibles ($854M of $923M); at ~$430M of acquired revenue, that is ~2.1x EV/sales for a lower-margin automatic-entrance install/service business that was initially margin-dilutive. Integrated into Americas; it added the services/aftermarket leg.
- 2024 tuck-ins. SOSS, Dorcas, Boss, Krieger, Unicel — ~$147M aggregate, premium hinges and adjacencies.
- The 2025 nine-deal spree. ~$631.6M total consideration (including a $30.3M earnout; $592.2M cash), anchored by ELATEC (€327.9M / ~$386.5M, German RFID/contactless readers) and spanning Next Door, Lemaar, Trimco, Novas, Gatewise (US multifamily access SaaS), Waitwhile (US cloud scheduling SaaS), UAP and Brisant (UK). The PPA was ~104% goodwill + intangibles (only ~$63.5M tangible) — Allegion was buying technology, IP and customer relationships, not hard assets.
- DCI (March 2026). West Coast hollow-metal doors and frames; low-double-digit EBITDA margin, ~30 bps of full-year Americas margin drag, limited FY2026 accretion — a strategic lead-time/cost play.
Is it disciplined or roll-up drift? The evidence leans disciplined bolt-on, with a roll-up-drift watch-flag. In its favor: ROIC held ~19% through ~$1.7B of deals; there have been no goodwill impairments in 2023–2025; the strategy is coherent (build an electronics/access-control platform around the mechanical core); and single-deal risk is low (a swarm of small tuck-ins rather than one bet-the-company deal). Against it: integrating nine deals in a single year plus DCI raises execution risk; goodwill+intangibles are now 52% of assets; and the capital is flowing disproportionately into the lower-return International segment (International assets +65%, +$10M OI). The returns on the 2025 spree are the central open question — too early to score, but the absence of write-downs and the durable ROIC are reassuring so far.
Buybacks and dividends. The dividend has compounded ~11%/year ($1.07/share in 2019 to $2.04 in 2025) at a conservative ~27% payout — sustainable and with room to grow. Buybacks have been used as the residual/throttle: a large $412.8M in FY2021 (unfortunately at the ~21x EBITDA multiple peak — the one buy-high episode), then throttled to $60–80M/year to fund M&A, $220M in FY2024, $80M in FY2025, $40M in Q1-2026, with a new $500M authorization approved April 15, 2026. Net share count fell modestly from 88.2M (2021) to 86.1M (2025) — buybacks largely offset SBC and funded M&A-over-price rather than aggressively shrinking the count. The capital-priority order is clear and reasonable: M&A first, dividend growth second, buyback as the flexible residual.
Incentives — a governance watch-item. The 2026 proxy shows annual-incentive metrics of Revenue + Adjusted Operating Income + Available Cash Flow, and a long-term mix of PSUs 50% (split 50% three-year adjusted EPS / 50% relative TSR vs. the S&P 400 Capital Goods Index) + Options 25% + RSUs 25%. Critically, there is no ROIC or return-on-capital metric anywhere in the incentive design. [Fact: 2026 DEF 14A.] An EPS-and-revenue-growth-and-TSR structure is the classic design that can reward accretive-but-low-return M&A and buybacks (both lift EPS) without penalizing ROIC dilution — a real concern for a company actively deploying capital into a 4%-ROA segment. CEO John Stone’s 2025 total compensation was $9.16M (~88% variable); CFO Michael Wagnes $3.07M; the CEO ownership guideline is 6x base. Mitigants: the 50%-relative-TSR PSU leg, the high ownership guideline, and — most persuasively — genuine open-market buying ( insider read). Net: a mild governance negative, partly offset by alignment.
Verdict: broadly disciplined and shareholder-aligned, with two amber flags. Cash is redeployed coherently into a higher-growth adjacency at returns that have so far preserved a ~19% ROIC; the dividend is conservative and growing; buybacks are sensibly throttled. The flags — no ROIC in compensation, and capital flowing into the low-return International segment — are watch-items, not disqualifiers, and are materially offset by the CEO’s and directors’ real open-market purchases.
8. Changes and Headwinds — Last Two Years
Leadership and governance. CEO John H. Stone (ex-Danaher) was appointed in ~July 2022, succeeding Dave Petratis, and owns the electronics-redeployment-plus-tuck-in strategy. The board added Gregg Sengstack (former Franklin Electric chair/CEO) in December 2024; General Counsel transitioned (Jeffrey Braun retired June 2025). The revolving credit facility was amended in December 2025 to support M&A and liquidity. None of these is thesis-threatening — they are constructive/governance-normal (a quality director add, orderly succession, M&A-supporting liquidity).
The Q1-2026 stumble — the proximate cause of the de-rating. Reported April 28, 2026, Q1-2026 was the first adjusted-EPS decline in years and the catalyst for the −7.1% single-day drop and the broader slide. The specifics: revenue >$1.0B (+9.7% reported, +2.6% organic); adjusted EPS $1.80, down 3.2%; adjusted operating margin 21.2%, −150 bps. Americas held up (revenue +6.9% reported / +4.5% organic, non-residential mid-single-digit on price, but margin −110 bps on negative mix and acquisition drag). The miss was International: revenue +21.5% reported but −5.3% organic, with margin −220 bps, almost entirely from a botched ERP implementation at one legacy European mechanical business that depressed production. Management was explicit that this is execution, not demand (“the customer orders are there, the backlog is there… it’s our execution that needs to improve”), and expects to recover the shortfall over the balance of the year — but also conceded it has had “a lot of struggles” with this one implementation.
Tariffs and inflation. Management flagged an incremental ~1% of COGS headwind in 2026 from a “flurry” of trade-policy changes (IEEPA, Section 122, Section 232) plus fuel inflation, to be offset dollar-for-dollar through price and cost actions (not yet in the market, hence not yet in the organic guide). The Mexican manufacturing base (the residential portfolio) is the key exposure. Management expects the net effect to be neutral to operating-income dollars and EPS — a claim, not yet a result.
Demand signals — mixed but not alarming. Against the headwinds, management characterized Americas non-residential specification activity as “strong… might go so far to even call it very strong in recent months… broad-based,” with no elongation in the spec-to-order timeline and no data-center crowding-out. Residential remains soft (new build weak, aftermarket “treading water”), and electronics decelerated on a tough comp but is reaffirmed as a long-term driver. The full-year guide was affirmed (organic +2–4%, adjusted EPS $8.70–8.90) with reported revenue raised to +6–8% for the DCI acquisition.
Verdict: the negatives are operational and cyclical, not structural. The thesis-relevant changes are a self-inflicted International ERP miss (management-claims-transitory), a tariff/margin overhang (claimed-neutral), soft residential, and decelerating electronics — set against still-strong non-residential spec activity. There are no capital-allocation, accounting, litigation or governance red flags. Whether these headwinds weaken or merely dent the thesis depends entirely on the non-residential cycle.
9. Risk Analysis
| # | Risk | Likelihood | Impact | Evidence basis |
|---|---|---|---|---|
| 1 | Non-residential construction rolls over into 2027 (the master risk) — new-construction volume air-pocket as late-cycle leading indicators (ABI, starts) weaken; Americas organic already carried by price, not volume | Medium | High | Q1-26 volume declines offset by price; ABI/non-res cycle late; 10-K names construction-market strength as top risk |
| 2 | Tariff / input-cost margin leak — the ~1%-of-COGS 2026 headwind is not fully offset by price/cost; margins keep compressing | Medium | Medium | Q1-26 margins −110/−220 bps by segment; offset is a management claim, not yet realized; heavy Mexico sourcing |
| 3 | International remains a low-return drag / ERP not recovered — the −5.3% organic stumble proves structural, not transitory; ELATEC build destroys capital at ~4% ROA | Medium | Medium | Intl assets +$740M for +$10M OI; ERP self-harm; segment margin 9% |
| 4 | Residential / smart-lock commoditization — Big-Tech and DIY price competition erodes the residential flank; phone-as-key disintermediates over time | Medium | Low-Med | Residential flat-to-down; smart-lock entrants; but commercial core insulated by codes |
| 5 | M&A integration / capital misallocation — nine 2025 deals + DCI integrate poorly; goodwill (52% of assets) impairs; ROIC dilutes | Low-Med | Medium | $1.7B M&A since 2022; no ROIC in comp; no impairments yet |
| 6 | Value trap / multiple stays compressed — even on in-line EPS, the stock stays <15x forward for another 12–18 months (the 5-yr dead-money base rate) | Medium | Medium | 5-yr total return ~+1.8%/yr; factor tape = late-cycle cyclical; negative Growth loading |
| 7 | Electronics mix dilutes the 45% gross margin — the secular shift toward lower-margin electronics/SaaS structurally lowers consolidated margin | Med-High | Low-Med | Electronics + bought-in International carry lower gross margins than mechanical core |
| 8 | FX translation — ~25% of revenue is non-US; euro/peso swings move reported results | Medium | Low | Q1-26 FX +10.9% Intl tailwind shows the two-way sensitivity |
| 9 | Key-person / strategy continuity — strategy is tied to CEO Stone’s redeployment plan | Low | Medium | Stone since 2022; deep bench; orderly governance |
| 10 | Catastrophic loss — life-safety product liability (a Von Duprin/fire-door failure) or major recall | Low | Med-High | Certified products; litigation-safe brand is itself a moat, but tail risk exists |
Overall risk read. This is a moderate-risk, investment-grade quality name whose risk profile is dominated by a single cyclical variable — risk #1, the non-residential construction cycle — to which risks #2, #6 and #7 are largely subordinate. There is no balance-sheet, accounting, customer-concentration or secular-impairment risk of the severe kind; the realistic worst case is a multi-quarter cyclical earnings dip plus a stuck-cheap multiple (a value trap), not a permanent loss of capital. The probability of a catastrophic/total loss is very low.
10. Valuation Discussion (Embedded Expectations)
Spot math. At $139.71 on 86.1M diluted shares, market capitalization is ~$12.0B; adding net debt of $1.62B gives an enterprise value of ~$13.7B. [Note: ROIC.ai’s year-end figures (mkt cap $13.7B / EV $15.3B) were struck at the higher FY2025-close price of $159.22; deflated to the current $139.71, mkt cap is ~$12.0B and EV ~$13.7B — the figures used throughout.] That yields: P/E ~18.8x trailing GAAP ($7.43); ~15.9x forward on the FY2026 adjusted-EPS midpoint of $8.80; EV/EBITDA ~13.8x trailing / ~13.0x forward; EV/Sales ~3.4x; a 5.7% equity FCF yield and ~1.5% dividend yield.
Against its own history. On ROIC.ai annual averages, EV/EBITDA ran 14.9x (2018) → 17.4x (2020) → 20.9x (2021 peak) → 13.6x (2023 trough) → 14.6x (2025); P/E averaged a 24.3x peak in 2021 to ~20x in 2025. Spot ~13.8x EBITDA / ~18.8x P/E sits in the lower half of the eight-year band, roughly one-third below the 2021 peak. The AZI valuation-index corroborates: the composite is at the 16.7th percentile of Allegion’s own multi-year history (P/E 17.4th, P/B 1.65th — near the cheapest book multiple it has ever traded — P/S 31st). On its own history, Allegion is cheap.
Embedded expectations — the crux number. With a WACC of ~7.5% (risk-free ~4.3%, equity-risk-premium ~5%, levered beta ~0.71 → cost of equity ~7.9%; after-tax cost of debt ~3.4% at ~15% weight) and a 5.0% FCF/EV yield, a Gordon-growth solve implies the market is pricing perpetual FCF growth of only g = WACC − yield ≈ 7.5% − 5.0% = ~2.5% (≈2.2% on an equity basis). At $139.71 the stock embeds ~2–2.5% perpetual growth — inflation/maturity-only — for a franchise that compounded EPS +39% over 2021→2025 and earns ~19% ROIC, two-to-three times its cost of capital. The price gives essentially no credit for real organic growth, for the electronics/M&A redeployment, or for the buyback. The cash economics are not in dispute; only the multiple is. That is the quantitative definition of the de-rated-quality setup.
Peer comparison. [ROIC.ai TTM, 2026-06-29.]
| Company | P/E | EV/EBITDA | EV/Sales | Op margin | ROIC | Read |
|---|---|---|---|---|---|---|
| Allegion (ALLE) | ~18.8x | ~13.8x | ~3.4x | 21.1% | ~19% | Best margins/ROIC of the group; mid-pack multiple |
| ASSA ABLOY (global #1) | ~32x | ~17–19x | ~3.9x | 15.5% | ~10% | Large premium — scale/breadth/secular narrative; wide gap for a lower-ROIC name |
| Fortune Brands (FBIN) | ~17.2x | ~9.9x | ~1.7x | ~14% | — | Cheaper — lower margin, heavier US-resi/R&R, hard de-rate |
| Masco (MAS) | ~14.9x | ~12.2x | ~2.0x | ~17% | — | Cheaper — resi repair/remodel, lower secular growth |
Allegion sits mid-pack and earns it: a wide (and only partly deserved) discount to the ASSA ABLOY compounder — the ~12-turn P/E gap is large for a higher-ROIC, higher-margin, more-focused franchise — and a deserved premium to the lower-margin, more residential-cyclical FBIN and MAS. Versus the broader quality-industrial cohort that typically trades 18–22x, ALLE at ~15.9x forward is at the cheap end.
Scenarios (FY2026–27).
| Case | Price band | Key assumptions | EV |
|---|---|---|---|
| Bear | ~$105–125 | Non-res rolls over (late-cycle ABI feeds 2027 starts), resi stays soft, International drag lingers, price/cost fails to fully offset tariffs; adj EPS slips to ~$8.40–8.60 (below guide); multiple compresses toward the 2023 trough ~11–12x EBITDA / ~13.5x P/E. ($8.50 × 13.5x ≈ $115.) | ~$11.0–12.4B |
| Base | ~$140–158 | Organic +2–4% (guide), ERP normalizes 2H, price/cost catches tariffs to ~neutral, adj EPS $8.70–8.90 with ~$9.2–9.4 visible FY27; holds ~16–17x forward P/E / ~13.5–14x EBITDA. ($8.80 × 16.5x ≈ $145; FY27 $9.3 × 16x ≈ $149.) | ~$13.5–14.6B |
| Bull | ~$175–195 | Non-res holds on spec backlog, electronics re-accelerates, International recovers, ELATEC/DCI accretive; adj EPS $9.3–9.6 FY27 and a renewed quality bid re-rates toward 19–20x P/E (still below 2021’s 24x). ($9.4 × 19.5x ≈ $183; revisits the Feb-2026 ATH.) | ~$16–18B |
The skew is favorable but not screaming — roughly −18% to the bear, +30% to the bull, with the base case spanning spot to ~+13%. The asymmetry is gated almost entirely on the non-residential construction cycle and on whether the Q1-2026 margin/International stumble is transitory.
Verdict. Allegion is priced as a no-growth, late-cycle building-products cyclical (~2–2.5% embedded perpetual growth) despite earning ~19% ROIC and compounding EPS at a high-single-digit-plus rate through a full cycle. The market is correctly pricing the cyclical risk and incorrectly (if the thesis holds) ignoring the quality. The valuation is the opportunity if the cycle holds and a value trap if it doesn’t — which is precisely why the embedded-expectations gap is wide but not riskless.
11. Variant Perception
Consensus. The Street is a tepid Hold — roughly 9 hold / 2 buy / 1 strong-buy, with price targets being cut toward the price after Q1-2026 (Morgan Stanley $165→$142, JPMorgan $170→$150, Barclays $165→$161), a median around $175 and an average near $161. [Web, 2026-06.] The consensus belief: “a good business, but a late-cycle non-residential cyclical with a tariff/margin overhang and a self-inflicted International stumble; fairly valued at ~16x forward until the cycle and margins clear.” Nobody is excited; the quality is acknowledged, the cycle worry caps the rating, and the marginal revision is down — i.e., sentiment is washing out rather than euphoric.
The strongest bull case. A ~19%-ROIC, 45%-gross-margin, spec-driven franchise — Schlage/Von Duprin/LCN locked into building codes and architect specifications, a real switching-cost-plus-intangibles moat — trading at its cheapest multiple in a decade (16.7th-percentile composite, ~15.9x forward vs. a 20–24x history). Embedded expectations price only ~2–2.5% perpetual growth, so any of several levers — electronics re-acceleration, International ERP recovery, accretive M&A redeployment, a 5.7% FCF yield funding buyback at a depressed price — closes the gap. The demand is non-discretionary and code-mandated (a low-ticket line item in a much larger project), making it more resilient than “construction cyclical” implies. A re-rate toward 19–20x on ~$9.3–9.5 FY2027 EPS gets back to ~$180 (the prior ATH) without needing peak multiples. And insiders are buying.
The strongest bear case. Non-residential construction is late-cycle — leading indicators point to a possible 2027 volume air-pocket — and Americas organic growth was carried by price, with volume flat, in Q1-2026; residential is flat-to-down and electronics decelerated. Tariffs add ~1% of COGS that price/cost may not fully offset; margins already compressed 110–220 bps by segment. International is a chronic, sub-scale, low-ROA drag that just self-inflicted an ERP miss. The 2025 M&A spree raises integration and capital-discipline risk and is depressing the buyback. And the factor tape agrees with the bears: five years of dead money, a negative Growth loading, rate-sensitive — a value trap that can stay cheap for years. The secular smart-lock/wallet-credential question hangs over the mechanical core.
The 3–5 assumptions that matter most, and what falsifies each side:
- Non-residential construction does not roll over hard into 2027 (institutional/spec backlog cushions). Falsifies the bull: two quarters of negative Americas organic volume (not just price) plus ABI sustained <48. Falsifies the bear: Americas organic volume stays positive and spec/order activity stays “strong.”
- Tariff/price-cost nets to neutral (management’s claim), not a sustained margin leak. Falsifies the bull: Americas adjusted margin keeps falling YoY for 2+ more quarters despite price. Falsifies the bear: Q2–Q3-2026 margins re-expand YoY as price catches cost.
- The International ERP stumble is transitory. Falsifies the bull: International organic stays negative into FY2027. Falsifies the bear: International organic turns positive by 2H-2026 as guided.
- The cheap multiple is the opportunity, not a permanent re-rate lower. Falsifies the bull: the stock stays <15x forward for another 12–18 months even on in-line EPS (value trap confirmed). Falsifies the bear: any clean print re-rates it toward 18–19x.
- Electronics growth + M&A redeployment create value (not just defend the base). Falsifies the bull: electronics keeps decelerating and acquired units dilute ROIC. Falsifies the bear: electronics re-accelerates to double-digit and ELATEC/DCI prove accretive.
Factor-positioning tie-in — where consensus may be offsides. The tape prices ALLE as a low-beta (0.71), rate-sensitive, late-cycle building-products cyclical — a heavy Home-Construction industry loading (+0.42), a negative Growth loading, a mild Value/Quality/Dividend tilt, and a five-year dead-money record (Sharpe ≈ 0). In other words, it is owned and discarded as a generic cyclical, not as the ~19%-ROIC compounder its economics imply, and the small Quality / negative Growth loadings show the market is not paying for the franchise quality at all. The variant-perception crux: if the Q1-2026 stumble is transitory and non-residential holds, the market is mispricing a quality franchise as a commodity cyclical at a decade-cheap multiple — the bull edge. If non-residential rolls and the multiple stays compressed, the factor tape is right and this is a value trap — the bear edge. The single swing variable is the non-residential construction cycle; tariffs, International and electronics are secondary noise around it. Importantly, the drawdown is de-rated quality, not a falling knife: a −30% maximum drawdown is a normal cyclical de-rate, orderly (beta 0.71, ~20% idiosyncratic vol), not a −50/−70% collapse, and the stock has already bounced +11% off its May low.
12. Fact vs. Interpretation Table
| # | Statement | Type | Basis |
|---|---|---|---|
| 1 | FY2025 revenue $4,067.3M; Americas $3,218.8M (79%) at 27.9% margin; International $848.5M at 9.0% | Fact | 10-K Note 20 / MD&A |
| 2 | ROIC ~19%, gross margin 45.2%, op margin 21.1% — best of the three global peers despite smallest | Fact | ROIC.ai profitability ratios, 2026-06-29 |
| 3 | The margin/ROIC gap is the moat made visible; strip spec lock-in/installed-base/brand and Americas margin converges toward ASSA’s ~15% | Interpretation | Greenwald analysis on the margin data |
| 4 | EPS compounded +39% (2021→2025) while the stock was flat; the move is pure multiple compression | Fact (data) / Interpretation (attribution) | EPS series + price history |
| 5 | At $139.71 the market embeds ~2–2.5% perpetual FCF growth | Interpretation | Gordon-growth solve at ~7.5% WACC, 5.0% FCF/EV |
| 6 | The aftermarket/installed-base “annuity” is real and high-margin | Interpretation/Assumption | Industry structure + ASSA ~67% aftermarket; ALLE does not disclose its split |
| 7 | The Q1-2026 International miss was a self-inflicted ERP failure, not a demand problem | Fact (management) / Interpretation (validation pending) | Q1-26 transcript; backlog cited but unverified externally |
| 8 | Non-residential is late-cycle and could roll into 2027 | Interpretation | ABI/cycle indicators; volume flat in Q1-26 |
| 9 | CEO Stone bought ~$5M of stock open-market (2022–24); several directors bought 2024–26 | Fact | Form 4 filings |
| 10 | Capital allocation is disciplined bolt-on with roll-up-drift risk; no ROIC in comp | Interpretation (discipline) / Fact (no ROIC metric) | M&A record + 2026 proxy |
| 11 | Net debt ~1.6x EBITDA, investment grade; ~$690M FCF, 5.7% yield | Fact | 10-K / cash-flow statement |
| 12 | This is de-rated quality, not a falling knife | Interpretation | FactorsToday drawdown/beta/idio-vol profile |
13. Open Questions
- What is the aftermarket/replacement vs. new-construction revenue split? Allegion does not disclose it; the installed-base annuity is asserted, not quantified. (ASSA discloses ~67% aftermarket as an industry comp.) This is the single most important undisclosed datum for sizing cyclicality.
- What is true recurring/SaaS ARR? Services & software is 6.8% of revenue, but the recurring software story behind the electronics narrative is opaque.
- What return is the 2025 M&A spree (especially ELATEC) actually earning? International assets rose +$740M for +$10M of operating income; the spree’s ROIC is the key value-creation question and is too early to score.
- Is the International ERP recovery real? Management cites backlog and improving production, but the catch-up has not yet been demonstrated in a reported quarter.
- Electronics gross margin vs. mechanical — how much does the mix shift dilute the 45% gross margin over the next five years?
- Within US non-residential, what is the institutional vs. commercial-office and renovation vs. new-build sub-mix? This calibrates exactly how cyclical the core really is.
14. What Must Be True
For the bull case to be right (the stock is a quality compounder mispriced as a cyclical at a decade-cheap multiple):
- US non-residential demand holds — Americas organic volume turns and stays positive through 2026–27, with specification activity converting to orders (not just price carrying growth).
- Margins re-expand: price/cost offsets the ~1%-of-COGS tariff headwind to neutral-or-better, and Americas adjusted operating margin returns to YoY expansion in 2H-2026.
- The International ERP stumble reverses — International organic turns positive by 2H-2026, and the ELATEC-led electronics platform earns a credibly improving return.
- The multiple re-rates: a clean print or two takes the stock back toward 18–19x forward as the market re-prices the quality.
- Falsification test: two consecutive quarters of negative Americas organic volume (price-only growth), or the stock remaining below ~15x forward for 12–18 months even on in-line EPS (value trap confirmed). Either kills the bull thesis.
For the bear case to be right (it’s a late-cycle cyclical / value trap):
- Non-residential construction rolls over into a 2027 volume air-pocket (ABI sustained <48 feeding starts), and Americas organic goes negative on volume.
- Margins keep leaking — tariffs/inflation outrun price, and segment margins compress for several more quarters.
- International stays a low-return drag (ERP not recovered, ELATEC dilutive), and the M&A spree’s ROIC disappoints / goodwill impairs.
- The multiple stays compressed regardless of in-line earnings — the five-year dead-money base rate persists.
- Falsification test: Americas organic volume stays positive and spec/order activity stays “strong” through 2026, and Q2–Q3-2026 margins re-expand YoY as price catches cost. Either breaks the bear thesis and validates the franchise.
The two falsification tests are mirror images, which is the point: this is a one-variable call on the non-residential construction cycle, and the next two-to-three prints — specifically Americas organic volume and the segment margin trend — will resolve it.
15. Source Appendix
See Appendix B (Source Appendix) below for the full list. Primary sources: Allegion plc FY2025 Form 10-K (filed 2026-02-17, alle-20251231) and the trailing five-year SEC corpus (10-Ks, 10-Qs, 8-Ks, DEF 14A, Form 3/4/5); the Q1-2026 earnings-call transcript (2026-04-28); public fundamentals, valuation-history percentiles, and factor-model data; and competitor benchmarks for ASSA ABLOY, dormakaba, Fortune Brands Innovations and Masco. Every non-obvious fact in the body is sourced.
The analysis proper is deliberately position-free and contains no buy/sell recommendation and no price target; the only stated position is the clearly-labeled Claude’s Take block at the top, which is the author’s own subjective opinion and general information only — not investment advice.
APPENDIX A — Standard Diligence Questionnaire
Allegion plc (NYSE: ALLE) — 2026-06-29
Supplemental to the main analysis. Answers are grounded in the underlying research; Fact/Interpretation/Assumption labels applied where it matters.
General
What thoughtful questions have other investors asked about this company? The dominant questions on the Q1-2026 call were: (1) whether the spec-to-order timeline in Americas non-residential is elongating (it is not, per management — “spec activity is strong… might call it very strong”); (2) whether data-center construction is crowding out other non-res projects (management: not in their space); (3) how the ~1%-of-COGS tariff headwind is split between price and cost actions and the lag to recovery; (4) the cause of, and recovery path from, the International ERP disruption; (5) whether the Americas negative mix in Q1 reflects customers trading down to value products like the Von Duprin 70 / Performance Series (management: no — it’s mix between product lines, not down-trading); and (6) capital-deployment priorities between buyback and M&A at the depressed price. The deeper buy-side question is the one this memo centers on: is the de-rating a cyclical mispricing of a quality compounder, or the start of a non-residential rollover?
Cyclicality & Earnings Nature
Are earnings at a cyclical high or low? Interpretation: mid-to-late cycle, nearer a high than a low on margins. Operating margin (21.1%) and gross margin (45.2%) are at multi-year highs after the post-2022 recovery, which argues earnings are not depressed. But volume is soft (Americas units +1.6% FY25, flat-to-negative Q1-26) and the cycle indicators are late, so unit earnings power may be near a cyclical plateau with downside risk into 2027.
Driven by the external environment or internal actions? Both. The 2022→2025 EPS recovery was internally driven (price/cost discipline, margin recovery, M&A, buyback); the forward risk is external (non-residential construction cycle, rates, tariffs).
How stable are revenues? Moderately stable for a building-products name — cushioned by institutional end-markets (schools/hospitals/government), code-mandated replacement demand, and an aftermarket annuity, but exposed to new-construction cyclicality and (in residential) the housing/rate cycle. Revenue fell only −4.7% in COVID-2020.
Outlook for products/services? Mechanical core: low-single-digit, price-led, durable. Electronics/access control (~26% of revenue): the secular growth driver, high-single/low-double-digit, but lumpy and partly acquired. Services & software (6.8%): small, growing.
How big will this market be — growing, shrinking, domestic or international? Global door-hardware ~$25–30B (low-single-digit growth); electronic access control ~$10–13B (high-single/low-double-digit). [Assumption: public/peer estimates.] Allegion’s profit is concentrated in the US/North-American non-residential slice — the richest, most defensible niche.
Business Quality & Competitive Moat
Is the industry getting more or less competitive? Stable-to-consolidating in the moaty US non-residential core (a tight Allegion/ASSA oligopoly protected by codes); more competitive in residential/DIY and in electronic access control, where Big-Tech and VC capital is entering.
How profitable is the business (ROIC, ROE)? ROIC ~19% (the clean metric); ROE 31.6% is distorted by buyback-driven negative tangible equity and should be discounted. Americas pre-tax segment ROA ~33%; International ~4%.
How profitable is the industry — competitors, barriers to entry? Allegion earns the highest margins/ROIC of the three global peers (vs ASSA op 15.5%/ROIC ~10%, dormakaba op 10.4%). Barriers: life-safety code certification (UL/ANSI/BHMA Grade-1), architect specification lock-in, brand trust, installed-base replacement, local distribution density.
Can the business be easily understood? Yes — it makes and sells the hardware on a door. The complexity is in the channel (spec-driven) and the segment asymmetry (Americas vs International), not the product.
Can it be undermined by foreign low-cost labor? Limited in the moaty core — code certification, spec relationships and brand insulate commercial hardware from generic low-cost imports; residential/DIY is more exposed (which is why Allegion itself manufactures residential in low-cost Baja, Mexico).
Do brands matter? Decisively, in commercial: Schlage, Von Duprin and LCN are category-defining, century-old, certified, litigation-safe brands that specifiers default to. Less so in commoditized residential.
Nature of competition? Specification and certification competition in commercial (win the architect’s spec); features/price competition in residential.
Customers’ switching costs? High in commercial — re-spec, re-certification, re-keying, installer re-training, brand-specific door prep; reinforced by BIM/Overtur workflow tools and (increasingly) credential/software ecosystems. Low in residential.
Financial Condition & Balance Sheet
Assets not fully recognized on the balance sheet? Yes — the brands (Schlage/Von Duprin/LCN are largely internally-generated and under-carried), the installed base / aftermarket annuity, and the specifier relationships. These are the real moat assets and are not on the balance sheet at fair value.
Off-balance-sheet liabilities? None material flagged (normal operating leases capitalized; standard warranty/pension). Life-safety product liability is a contingent tail risk.
How conservative is the accounting? Sound — cash conversion >1.0x for seven years, modest SBC (~$30M/yr), no goodwill impairments, no aggressive add-backs (the GAAP-to-adjusted gap is mostly acquisition intangible amortization). The main “soft” area is the 52%-of-assets goodwill/intangible load from M&A.
How CapEx-hungry is the business? Low — capex ~$90M on $4.1B revenue (~2.2% of sales), supporting a ~5.7% FCF yield. This is a high-FCF-conversion, low-capital-intensity model.
Capital Allocation & Management
How much FCF, and how is it used? ~$690M FCF (FY25). Priority order: M&A first (~$1.7B since 2022 — Stanley Access, the 2025 nine-deal spree incl. ELATEC, DCI), dividend growth second (~11%/yr, ~27% payout), buyback as the residual throttle ($500M newly authorized April 2026).
Significant acquisitions recently? Yes — the 2025 nine-deal spree (~$632M, ELATEC the ~$387M anchor) and DCI (March 2026); Stanley Access ($923M) in 2022.
Buying back shares? Modestly — net share count fell 88.2M→86.1M (2021→2025); buybacks were throttled to fund M&A. $40M in Q1-26; $500M authorized.
Issuing large amounts of stock to insiders? No — SBC is modest (~$30M/yr, ~0.7% of revenue).
Compensation policy / incentives? AIP = Revenue + Adjusted OI + Available Cash Flow; LTI = PSUs 50% (adj-EPS + relative TSR) / options 25% / RSUs 25%. No ROIC metric anywhere — a governance watch-item, partly offset by a 6x ownership guideline and genuine insider buying. CEO Stone 2025 comp $9.16M (~88% variable).
Motivations of management? Aligned-with-caveat. The CEO and several directors have made genuine open-market purchases (Stone ~$5M, 2022–24), a strong alignment signal; the lack of an ROIC hurdle is the offsetting concern given active M&A.
Valuation & Market Data
ADR, MLP, or K-1 issuer? None — Allegion is an Irish-domiciled plc but a US filer (full 10-K), an ordinary NYSE common share, not an ADR, MLP or K-1 issuer. No K-1.
Dividend policy? ~1.5% yield, ~$2.04/share, ~27% payout, ~11%/yr growth — conservative and growing.
How profitable is the business? Very — best-in-class margins and ~19% ROIC (see above).
Is net income diverging from cash from operations? No — OCF/NI conversion has been >1.0x for seven straight years; FY25 OCF $783.8M on NI $643.8M (1.22x). Healthy.
Risks & Downside
What would cause the stock to decline? A non-residential construction rollover (the master risk), a sustained tariff/margin leak, a failure of the International ERP recovery, a value-trap multiple that stays compressed, or M&A disappointment/goodwill impairment.
Risk of a catastrophic loss? Low. The realistic worst case is a multi-quarter cyclical earnings dip plus a stuck-cheap multiple — not a permanent impairment. Investment-grade balance sheet (1.6x net leverage), strong FCF, no secular kill-shot to the commercial core. A life-safety product-liability event is a low-probability tail.
Chance of a total loss? Negligible — a durable, cash-generative, investment-grade franchise.
Recent News & Events
Has the business environment changed recently? Yes — Q1-2026 (reported 4/28/26) brought the first adjusted-EPS decline in years (−3.2%), a self-inflicted International ERP disruption (−5.3% organic), ~110–220 bps of segment margin compression, decelerating electronics, soft residential, and a new ~1%-of-COGS tariff headwind. Management affirmed full-year organic +2–4% and adjusted EPS $8.70–8.90 and characterized the International issue as transitory and Americas spec activity as “strong.”
Significant acquisitions? DCI (West Coast doors, March 2026) added to the FY25 nine-deal spree.
Change in accounting policies? None flagged.
Recent changes — new markets, facilities, management? CEO Stone since 2022; director Sengstack added Dec-2024; GC transition mid-2025; revolver amended Dec-2025; ELATEC builds out the International electronics platform; DCI improves West Coast manufacturing reach.
APPENDIX B — Source Appendix
Allegion plc (NYSE: ALLE) — 2026-06-29
Primary sources first; every non-obvious fact in the memo traces to an entry in ALLE_research_log.txt. Facts are separated from interpretation throughout the body.
Primary — SEC filings (US filer; trailing 60-month corpus mirrored locally to output/ALLE/sources/)
- Allegion plc Form 10-K, FY2025 — filed 2026-02-17 (alle-20251231). Item 1 Business (products, brands, industry & competition, customers, production, seasonality, human capital); Item 7 MD&A (consolidated + segment results, revenue bridges); Note 20 (segment + revenue disaggregation); acquisitions notes (Stanley Access, 2024/2025 deals, PPAs); debt/liquidity. https://www.sec.gov/Archives/edgar/data/1579241/000157924126000007/alle-20251231.htm
- Allegion 10-Ks FY2019–FY2024 — filed 2020-02-18 through 2025-02-18 (five-year trend, margin/EPS history, prior-year segment data).
- Allegion 10-Q, Q1 2026 — filed 2026-04-28 (alle-20260331) — Q1 segment detail, balance sheet, cash flow.
- DEF 14A / DEFA14A proxy statements 2021–2026 — latest 2026-04-17. Executive compensation metrics (AIP: Revenue/Adj OI/ACF; LTI: PSU adj-EPS + relative TSR vs S&P 400 Capital Goods, options, RSUs), CEO/CFO pay, ownership guidelines, board composition.
- Form 3/4/5 (384 Form 4s in the 5-yr corpus) — insider transactions: CEO Stone open-market purchases (2022-10-31, 2023-07-28, 2024-07-30, 2024-12-04, ~$5.08M total); director purchases (Mizell 2024, Peters 2025-11-25, Main 2026-03-12); routine grant/vest/sell activity.
- 8-K material events — incl. 2024-12-05 (Sengstack director appointment), 2025-05-20/2025-12-09 (credit-agreement matters), 2026-04-15 ($500M buyback authorization), quarterly earnings 8-Ks.
Primary — Company disclosures
- Allegion Q1 2026 earnings call transcript — 2026-04-28 (John Stone / Michael Wagnes). Source: ROIC.ai
get_latest_earnings_call. Used for Q1 print, FY26 guide, tariff commentary, International ERP disclosure, spec-activity color, capital-deployment commentary. - Allegion Investor Relations — investor.allegion.com (Investor Day long-term framework: high-single-digit revenue growth, accretive capital deployment, ~35%+ core incrementals).
Quantitative data sources (third-party aggregated; reconciled to filings)
- ROIC.ai MCP — income statement, balance sheet, cash flow, profitability/credit/liquidity ratios, per-share data, enterprise value, valuation multiples (2018–2025) for ALLE; competitor profitability benchmarks for ASSA ABLOY (ASSA-B.ST), dormakaba (DOKA.SW), Fortune Brands Innovations (FBIN), Masco (MAS). Accessed 2026-06-29.
- AZI (azitrading.com) — 5-year daily price/OHLCV CSV (split/dividend-adjusted; EMAs, beta, alpha); valuation_index own-history percentile ranks (composite 16.7th; P/E 17.4th, P/B 1.65th, P/S 31st). Accessed 2026-06-29.
- FactorsToday (factorstoday.com) — factor loadings (Market, Value, Quality, Momentum, LowVol, Growth, InterestRate, Home-Construction, Industrials), leaderboard (risk-adjusted returns/Sharpe/max-drawdown by horizon), stock-info (beta, alpha, relative strength), specific-vol, related-stocks. Accessed 2026-06-29.
- SEC EDGAR XBRL (
scripts/edgar.sh) — CIK 0001579241; filing index and concept cross-checks.
Industry / competitor framing
- Industry structure, market sizing (access-control ~$10–13B, ~7.7–8.9% CAGR; ~two-thirds aftermarket), and the code/specification barrier framework drawn from public industry data and competitor disclosures (ASSA ABLOY, the #1 global peer). Dated third-party TAM/CAGR figures treated as framework, not current data.
Consensus / market data
- Sell-side ratings and price targets (Hold consensus ~9H/2B/1SB; PTs cut toward spot — Morgan Stanley $142, JPMorgan $150, Barclays $161; average ~$161, median ~$175) — public aggregators (TipRanks / StockAnalysis), accessed 2026-06.
Analytical frameworks
- Greenwald & Kahn, Competition Demystified — barriers to entry; customer captivity / intangibles / economies-of-scale advantage types; market-share-stability and ROIC tests (per the installed
investment-research-frameworksskill). - Marathon Asset Management, Capital Returns — supply-side capital-cycle analysis; the asset-growth flag on the International M&A redeployment.
Note on figures: ROIC.ai year-end market-cap/EV ($13.7B / $15.3B) were struck at the FY2025-close price of $159.22; the memo deflates these to the current $139.71 (mkt cap ~$12.0B, EV ~$13.7B). FCF is computed as OCF less capex (~$690M), as ROIC.ai’s “free cash flow” field reports OCF unadjusted for capex.